JBD publishes original research, reviews, methods papers, and data resources that apply bioinformatics to diabetes and metabolic disease. Submissions should demonstrate rigorous computational methods and clear clinical or biological interpretation.

• Title page with author affiliations and corresponding author details
• Structured abstract with objectives, methods, results, and conclusions
• Introduction that defines the diabetes context and research gap
• Methods with detailed data sources, preprocessing, and analytics
• Results with validation metrics and clear interpretation
• Discussion linking findings to diabetes outcomes or mechanisms
• Conclusion highlighting key contributions and future work

• Use clear headings and consistent terminology
• Define abbreviations and gene or protein symbols at first use
• Provide units for all measurements and clinical metrics
• Include figure legends that describe sample sizes and data sources
• Prepare tables in editable format with clear headings
• Label supplementary files clearly and reference them in the text

Authors should provide data availability statements and, when possible, deposit data in trusted repositories. Code or pipelines should be shared or documented to support reproducibility.

• Include accession numbers or repository links
• Describe preprocessing and quality control steps
• Document software versions and computational environments
• State any access restrictions for sensitive data

• Submit high resolution figures in standard formats
• Label axes and include units for quantitative plots
• Provide color blind friendly palettes when possible
• Ensure tables are editable and include footnotes

• Ensure references are complete and consistent
• Include DOIs where available
• Use standard citation formats
• Confirm all in text citations appear in the reference list

• Provide ethics approval and consent statements
• Disclose conflicts of interest and funding sources
• Follow reporting standards for clinical or omics studies
• Describe limitations and generalizability

JBD uses single blind peer review. Reviewers evaluate study rigor, data quality, and clarity of reporting. Initial decisions are typically issued within two to four weeks depending on reviewer availability.

Accepted manuscripts move to production for copyediting, proof review, and DOI registration. Articles are published under CC BY 4.0 to support open access reuse with attribution.

Authors should review proofs promptly to confirm accuracy of figures, tables, and metadata.

APCs are applied after acceptance and cover peer review management, production, and archiving services. Partial waivers may be available for eligible authors. Contact the editorial office for guidance.

• Scope alignment confirmed
• Data availability statement included
• Validation results reported
• Cover letter prepared with scope summary
• Ethics and consent statements included

For questions about formatting or submission steps, contact [email protected].

JBD is committed to rigorous, transparent publishing in bioinformatics and diabetes research. We emphasize reproducible computational methods, clear data provenance, and ethical compliance across all article types.

The editorial office supports authors, editors, and reviewers with clear guidance and responsive communication. For questions about scope or workflow, contact [email protected].

We encourage continuous improvement in reporting practices and share updates that help the community maintain high standards in computational and translational diabetes research.